Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2209 - 2216 of 11617 results
FTC, DOJ Launch Proceeding to Revise Antitrust Merger Guidelines
January 19, 2022| Blog| Viewpoint
Entire Market Value Rule Strikes Again in WDTX
January 19, 2022| Blog| Viewpoint
Legal ESG Summit Resources
January 19, 2022| Video| Viewpoint
Nurturing a Community-Based Approach to Food Access
January 18, 2022| Article| Viewpoint
Co-Owner of Clinical Trial Company Pleads Guilty to Obstruction of Justice in Connection with Falsification of Clinical Trial Data
January 18, 2022| Blog| Viewpoint
Preparation for 2021 Fiscal Year-End SEC Filings and 2022 Annual Shareholder Meetings
January 18, 2022| Advisory| Viewpoint
Patent Owner Tips for Surviving an Instituted IPR: From Depositions to Sur-Replies
January 14, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.